Table 2 |
|||
|
Surgical process characteristics in TKA patients before and after implementation of a clinical pathway were found comparable. |
|||
|
before pathway implementation |
after pathway implementation, without personal briefing |
after pathway implementation and personal briefing |
|
|
(n = 132) |
(n = 70) |
(n = 58) |
|
|
|
|||
|
surgery performed by trial investigator |
25% |
30% |
22% |
|
|
|||
|
median duration of surgery |
88 min |
83 min |
87 min |
|
|
|||
|
median duration of indoor treatment |
9 days |
9 days |
9 days |
|
|
|||
|
patients with PCCL1 „0" |
42% |
60% |
55% |
|
|
|||
|
patients with PCCL1 „3" or „4" |
34% |
27% |
24% |
|
|
|||
|
distribution characteristics for surgical process characteristics assessed in 132 patients, who underwent total knee arthroplasty (TKA) before implementation of a critical pathway on TKA, versus 128 patients, who underwent TKA after path implementation (the latter being stratified for attendance of a personal briefing as a voluntary part of the pathway) 1PCCL = patient comorbidity complexicity level |
|||
|
Krummenauer et al. BMC Health Services Research 2011 11:338 doi:10.1186/1472-6963-11-338 |
|||
